// App-Quantinova.ai

4637 : Chk1 inhibition: a promising targeted treatment for head and neck squamous cell carcinoma

Researchers

Presenter

  • Anne M. van Harten

Principal Investigators

  • Marijke Stigter-van Walsum

  • Marijke Buijze

  • Boudewijn Jm Braakhuis

  • Ruud H. Brakenhoff

Medical Centers

  • VU University Medical Center, Amsterdam, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma of the head and neck

  • Oral cancer

  • Tuberculosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved